Overview

Update
Total Equity Funding
$12.2M in 1 Round from 3 Investors
Most Recent Funding
$12.2M Series B on May 27, 2010
Headquarters:
Cambridge
Description:
Funxional Therapeutics develops pharmaceutical products focusing on the treatment of various diseases and disorders.
Founders:
, , ,
Categories:
Pharmaceutical, Health Care, Biotechnology
Website:
http://www.funxionaltherapeutics.com

Company Details

Update

Funxional Therapeutics Ltd. develops pharmaceutical products in the United Kingdom. Its product candidates include BN83470 for the treatment of respiratory indications, initially asthma; BN83250 for the prevention of surgical adhesion formation and for the treatment of stroke; and FX125L, an orally available small molecule that belongs to a therapeutic class named broad spectrum chemokine inhibitors. The company also offers early stage preclinical programs that focus on Alzheimer's disease, autoimmune disorders, and pain and diabetes. Funxional Therapeutics Ltd. as founded in 2005 and is based in Cambridge, the United Kingdom.

Funding Rounds (1) - $12.2M

Update
DateAmount / RoundValuationLead InvestorInvestors
May, 2010$12.2M / Series B3

Current Team (2)

Update

Board Members and Advisors (3)

Update

News (1)

Update

Offices/Locations (1)

Update
  • Office

    Wellington House

    East Road

    Cambridge, CB1 1BH

    GBR

Past Team (3)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos